A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

ABSTRACT: The primary objective of the study is to estimate the antitumor efficacy of SOT101 in combination with pembrolizumab in selected tumors.

DISEASE(S): Ovarian Cancer Nos,Metastatic Colorectal Cancer,Carcinoma,Colorectal Cancer,Cutaneous Squamous Cell Carcinoma,Carcinoma, Squamous Cell,Ovarian Cancer,Prostatic Neoplasms,Advanced/refractory Solid Tumors,Non-small Cell Lung Cancer,Colorectal Neoplasms,Non-small Cell Lung Cancer Nos,Carcinoma, Non-small-cell Lung,Carcinoma, Hepatocellular,Ovarian Neoplasms,Castration-resistant Prostate Cancer,Hepatocellular Carcinoma Recurrent,Hepatocellular Carcinoma

PROVIDER: 2405953 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR